

Publisher: Bentham Science Publishers
E-ISSN: 1873-4316|13|10|2026-2045
ISSN: 1389-2010
Source: Current Pharmaceutical Biotechnology, Vol.13, Iss.10, 2012-08, pp. : 2026-2045
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Mouse Models of Primary Sjogren’s Syndrome
Current Pharmaceutical Design, Vol. 21, Iss. 18, 2015-06 ,pp. :


Primary Sjogren's Syndrome and the Type I Interferon System
Current Pharmaceutical Biotechnology, Vol. 13, Iss. 10, 2012-08 ,pp. :


Primary Sjogren's Syndrome: Time for Prospective Cohorts
Current Pharmaceutical Biotechnology, Vol. 13, Iss. 10, 2012-08 ,pp. :




Anti-CD20 Antibody in Primary Sjogren’s Syndrome Management
Current Pharmaceutical Biotechnology, Vol. 15, Iss. 6, 2014-06 ,pp. :